Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?

Journal of Clinical Pathology

Volumn 67, Issue 2, 2014, Pages 97-104

  Ng, Keng Lim ^a,b,c   Rajandram, Retnagowri ^a,c   Morais, Christudas ^a   Yap, Ning Yi ^c   Samaratunga, Hema ^d   Gobe, Glenda C ^a   Wood, Simon T ^b  

^a TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d Aquesta Pathology   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

CANCER STAGING; CHROMOPHOBE ADENOMA; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HUMAN; KIDNEY CARCINOMA; KIDNEY CHROMOPHOBE; KIDNEY TUMOR; MEDICAL HISTORY; METASTASIS; NEPHRECTOMY; NEPHRON SPARING SURGERY; ONCOCYTOMA; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TUMOR DIFFERENTIATION;

EID: 84893681497     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201895     Document Type: Review

References (73)

1. Ljungberg B, Campbell SC, Choi HY, et al. The epidemiology of renal cell carcinoma. Eur Urol 2011;60:615-21.
2. Duchene DA, Lotan Y, Cadeddu JA, et al. Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology 2003;62:827-30. (Pubitemid 37421225)
3. Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 2008;34:193-205.
4. Schachter LR, Cookson MS, Chang SS, et al. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol 2007;21:819-23. (Pubitemid 47443652)
5. Yusenko MV. Molecular pathology of renal oncocytoma: A review. Int J Urol 2010;17:602-12.
6. Oxley JD, Sullivan J, Mitchelmore A, et al. Metastatic renal oncocytoma. J Clin Pathol 2007;60:720-2. (Pubitemid 46975235)
7. Delongchamps NB, Galmiche L, Eiss D, et al. Hybrid tumour 'oncocytomachromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases. BJU Int 2009;103:1381-4.
8. Zippel. Zur Kenntnis der Oncocytome. Virchows Arch A Pathol Anat 1942;308:360-82.
9. Klein MJ, Valensi QJ. Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm. Cancer 1976;38:906-14.
10. Storkel S, Pannen B, Thoenes W, et al. Intercalated cells as a probable source for the development of renal oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1988;56:185-9.
11. Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:207-17. (Pubitemid 15095927)
12. Thoenes W. SSaRHJ. Histopathology and classification of renal cell tumours (adenomas, oncoccytomas, carcinomas). The basic cytological amd histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-43. (Pubitemid 16021498)
13. Amin R, Anthony P. Metastatic renal oncocytoma: A case report and review of the literature. Clin Oncol (R Coll Radiol) 1999;11:277-9. (Pubitemid 29425763)
14. Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006;175:425-31. (Pubitemid 43067318)
15. Kawaguchi S, Fernandes KA, Finelli A, et al. Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance. J Urol 2011;186:1218-22.
16. Kurup AN, Thompson RH, Leibovich BC, et al. Renal oncocytoma growth rates before intervention. BJU Int 2012;110:1444-8.
17. Cindolo L, de ITA, Schips L, et al. Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology 2005;65:681-6.
18. Vera-Badillo FE, Conde E, Duran I. Chromophobe renal cell carcinoma: a review of an uncommon entity. Int J Urol 2012;19:894-900.
19. Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006;49:798-805.
20. Khoo SK, Bradley M, Wong FK, et al. Birt-Hogg-Dube syndrome: mapping of a novel hereditary neoplasia gene to chromosome 17p12-q11.2. Oncogene 2001;20:5239-42. (Pubitemid 32844055)
21. Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer cell 2002;2:157-64. (Pubitemid 41039116)
22. Warfel KA, Eble JN. Renal oncocytomatosis. J Urol 1982;127:1179-80. (Pubitemid 12088820)
23. Adamy A, Lowrance WT, Yee DS, et al. Renal oncocytosis: management and clinical outcomes. J Urol 2011;185:795-801.
24. Volpe A, Novara G, Antonelli A, et al. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int 2012;110:76-83.
25. Tobias Klatte K-rH, Jonathan W. Said, Malte Bohm. Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol-Semin Orig Investig 2008;26:604-09.
26. PerezOrdonez B, Hamed G, Campbell S, et al. Renal oncocytoma: A clinicopathologic study of 70 cases. Am J Surg Pathol 1997;21:871-83.
27. Akbulut S, Senol A, Cakabay B, et al. Giant renal oncocytoma: a case report and review of the literature. J Med Case Rep 2010;4:52.
28. Romis L, Cindolo L, Patard JJ, et al. Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 2004;45:53-7; discussion 57
29. Dechet CB, Bostwick DG, Blute MJ, et al. Renal oncocytoma: Multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma. J Urology 1999;162:40-2. (Pubitemid 29420875)
30. Trpkov K, Yilmaz A, Uzer D, et al. Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features. Histopathology 2010;57:893-906.
31. Davis CJ MF, Sesterhenn IA, Ho CK. Renal Oncocytoma. Clinicopathological study of 166 patients. J Urogenital Pathol 1991;1:41-52.
32. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-24. (Pubitemid 36514472)
33. Yusenko MV. Molecular pathology of chromophobe renal cell carcinoma: a review. Int J Urol 2010;17:592-600.
34. Kim JK, Kim TK, Ahn HJ, et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 2002;178:1499-506. (Pubitemid 34547840)
35. Remark RR, Berquist TH, Lieber MM, et al. Magnetic resonance imaging of renal oncocytoma. Urology 1988;31:176-9. (Pubitemid 18066286)
36. Choudhary S, Rajesh A, Mayer NJ, et al. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009;64:517-22.
37. Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 2010;195:W421-7.
38. Aide N, Cappele O, Bottet P, et al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 2003;30:1236-45. (Pubitemid 37205377)
39. Ramdave S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001;166:825-30. (Pubitemid 32750957)
40. Young JR, Margolis D, Sauk S, et al. Clear Cell Renal Cell Carcinoma: Discrimination from Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT. Radiology 2013;267:444-53.
41. Bird VG, Kanagarajah P, Morillo G, et al. Response by authors re: Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography. World J Urol 2013;31:1011-2.
42. Barocas DA, Rohan SM, Kao J, et al. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J Urol 2006;176:1957-62. (Pubitemid 44633153)
43. Kuroda N, Tanaka A, Yamaguchi T, et al. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol 2013;46:49-55.
44. Mazal PR, Exner M, Haitel A, et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Human pathology 2005;36:22-8. (Pubitemid 40215630)
45. Geramizadeh B, Ravanshad M, Rahsaz M. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Indian J Pathol Microbiol 2008;51:167-71. (Pubitemid 351961349)
46. Latham B, Dickersin GR, Oliva E. Subtypes of chromophobe cell renal carcinoma: an ultrastructural and histochemical study of 13 cases. Am J Surg Pathol 1999;23:530-5. (Pubitemid 29214955)
47. Liu L, Qian J, Singh H, et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007;131:1290-7. (Pubitemid 47257641)
48. Bing Z, Lal P, Lu S, et al. Role of carbonic anhydrase IX, alpha-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study. Ann Diagn Pathol 2013;17:58-62.
49. Lee HW, Lee EH, Lee CH, et al. Diagnostic Utility of Caveolin-1 and MOC-31 in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma. Korean J Urol 2011;52:96-103.
50. Ehsani L, Seth R, Bacopulos S, et al. BCA2 is differentially expressed in renal oncocytoma: an analysis of 158 renal neoplasms. Tumour Biol 2013;34:787-91.
51. Demirovic A, Dzombeta T, Tomas D, et al. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma. Pathol Res Pract 2010;206:695-9.
52. Langner C, Ratschek M, Rehak P, et al. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod Pathol 2004;17:180-8. (Pubitemid 41656514)
53. Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005;29:747-54. (Pubitemid 40734424)
54. Gudbjartsson T, Hardarson S, Petursdottir V, et al. Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases. BJU Int 2005;96:1275-9. (Pubitemid 41743923)
55. Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol 1998;110:782-7. (Pubitemid 28541555)
56. Abrahams NA, MacLennan GT, Khoury JD, et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004;45:593-602. (Pubitemid 40029819)
57. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol 1995;154:964-7.
58. Wang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am J Surg Pathol 2005;29:640-6. (Pubitemid 40577874)
59. Tickoo SK, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am J Surg Pathol 1998;22:419-24. (Pubitemid 28164547)
60. Huang W, Kanehira K, Drew S, et al. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study. Appl Immunohistochem Mol Morphol 2009;17:12-7.
61. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004;45:452-9. (Pubitemid 39524319)
62. Huo L, Sugimura J, Tretiakova MS, et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 2005;36:262-8. (Pubitemid 40404009)
63. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2004;121:878-83. (Pubitemid 38669283)
64. Ray ER, Goodwill J, Chandra A, et al. Exploring the Potential of Immunohistochemistry to Identify Renal Oncocytoma. Br J Med Surg Urol 2011;4:8-12.
65. Patton KT, Tretiakova MS, Yao JL, et al. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol 2004;28:1045-50. (Pubitemid 38971429)
66. Brunelli M, Delahunt B, Gobbo S, et al. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Am J Clin Pathol 2010;133:116-26.
67. Shen SS, Krishna B, Chirala R, et al. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol 2005;18:933-40. (Pubitemid 41059954)
68. Adley BP, Gupta A, Lin F, et al. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2006;126:79-85. (Pubitemid 44025074)
69. Taki A, Nakatani Y, Misugi K, et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol 1999;12:310-7. (Pubitemid 29133853)
70. Leroy X, Moukassa D, Copin MC, et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000;37:484-7. (Pubitemid 30157812)
71. Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathol 2006;125:392-8. (Pubitemid 43327708)
72. Wu SL, Kothari P, Wheeler TM, et al. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol 2002;15:712-7. (Pubitemid 34787306)
73. Stopyra GA, Warhol MJ, Multhaupt HA. Cytokeratin 20 immunoreactivity in renal oncocytomas. J Histochem Cytochem 2001;49:919-20. (Pubitemid 32565985)